Company: IMRX
Filing Date: 2025-06-17
Form Type: 8-K
Source: 0001790340-25-000077
Chunk: 2

Company: Immuneering Corp
Filing Date: 2025-06-17
Form: 8-K
Item: Item 8.01
Chunk 2
---
 to update such forward-looking statements at some point in the future, unless required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this Current Report.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           IMMUNEERING CORPORATION                                                
  Date: June 17, 2025      By:                          /s/ Michael D. Bookman                    
                                                        Name: Michael D. Bookman                  
                                                        Title: Chief Legal Officer and Secretary